Exploring Fagonia cretica and Berberis lycium as α-Amylase Inhibitors: Potential Therapeutic Strategies for Diabetes Mellitus Investigated through in vitro and in silico Approaches
Yan-Kun Chen1,2, Imtiaz Ahmad3, Noor Rahman3, Shafiullah Shafiullah4, Haroon Khan5, Luca Rastrelli6, Said Alam7, Yousef A. Bin Jardan8, Mohammed Bourhia9★, Changan Jiang1,2★★ Corresponding author
- 1Nanomedical Technology Research Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China.
- 2Precision Medicine R&D Center, Zhuhai Institute of Advanced Technology, Chinese Academy of Sciences, Zhuhai, Guangdong Province, China.
- 3Department of Biochemistry, Abdul Wali Khan University Mardan, KP, Pakistan.
- 4Department of Pharmacy, Abdul Wali Khan University Mardan, KP, Pakistan.
- 5Department of Pharmacy, Faculty of Pharmaceutical Sciences, Superior University, Lahore, Punjab, Pakistan.
- 6Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.
- 7Department of Biochemistry, Hazara University, Mansehra, KP, Pakistan.
- 8Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- 9Department of Biology, Laboratory of Biotechnology and Natural Resources Valorization, Faculty of Sciences of Agadir, Ibn Zohr University, Agadir, Souss-Massa-Draa, Morocco.
CORRESPONDENCE
Mohammed Bourhia
Department of Biology, Laboratory of Biotechnology and Natural Resources Valorization, Faculty of Sciences of Agadir, Ibn Zohr University, Agadir, Souss-Massa-Draa, Morocco.
Received: 13-02-2024; Accepted: 18-07-2024.
Volume 21, Issue 2 · pp. 673–683 · PUBLISHED 2025 · DOI: 10.1177/09731296241286281
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Growing diabetes prevalence prompts investigation into plant-derived compounds’ potential to inhibit α-amylase, offering novel therapeutic avenues for treating diabetes mellitus (DM). Objectives: In the current study, ethanolic and methanolic extracts of Fagonia cretica and Berberis lycium were evaluated against α-amylase. Materials and Methods: The inhibitory activity of ethanolic and methanolic extracts was analyzed based on their IC50 values. An in vitro activity of α-amylase inhibition was performed, followed by molecular docking and molecular dynamics (MD) simulation of selected compounds. Results: Results indicated that F. cretica and B. lycium extracts have strong inhibitory effects against α α-amylase. In ethanolic and methanolic extracts, the methanolic B. lycium extract was the most potent with an IC50 value of 2.10 µg/mL; the ethanolic B. lycium, ethanolic, and methanolic F. cretica extracts also showed significant anti-α-amylase effects with IC50 values of 3.88, 4.09, and 7.26 µg/mL, respectively. Further, a total of 36 phytochemicals were docked against the α-amylase enzyme to explore the binding mode of these phytochemicals. Docking results confirmed that most of the phytochemicals accommodate well in the active site of α-amylase and made strong interactions compared to the standard drug acarbose. Also, the MD simulation results confirmed that both phytochemicals revealed greater stability than the standard acarbose. Conclusion: Based on these results, we concluded that the extract showed good effectiveness and further in vivo study is needed to manage DM.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Chen, Y., Ahmad, I., Rahman, N., Shafiullah, S., Khan, H., Rastrelli, L., Alam, S., Jardan, Y. A. B., Bourhia, M., & Jiang, C. (2025). Exploring Fagonia cretica and Berberis lycium as α-Amylase Inhibitors: Potential Therapeutic Strategies for Diabetes Mellitus Investigated through in vitro and in silico Approaches. Pharmacognosy Magazine, 21(2), 673–683. https://doi.org/10.1177/09731296241286281
